UROGENITAL RADIOLOGY / ORIGINAL PAPER
 
KEYWORDS
TOPICS
ABSTRACT
Purpose:
We aim to evaluate the reproducibility of these features and apply machine learning algorithms to predict cancer diagnosis.

Material and methods:
We analyzed magnetic resonance (MR) images from a cohort of 82 individuals, split between 41 prostate cancer patients and 41 healthy controls. A total of 215 radiomic features were extracted from T2-weighted and ADC images using the Software Environment for Radiomic Analysis (SERA). Intraclass correlation coefficient (ICC) analysis was used to assess the reproducibility of features, and Pearson’s correlation was applied to remove redundant features. After feature selection, seven dimensionality reduction techniques, including principal component analysis (PCA), kernel PCA, linear discriminant analysis, and locally linear embedding, were applied to preprocess the radiomic features. Ten machine learning algorithms, including support vector machines (SVM), random forests, neural networks, logistic regression, and ensemble methods such as CatBoost and AdaBoost, were utilized to classify cancerous versus non-cancerous tissues. Model performance was evaluated using accuracy and AUC-ROC metrics.

Results:
The results showed that features with high reproducibility (ICC > 0.75) contributed significantly to the performance of machine learning models. SVM, neural networks, and logistic regression achieved the highest accuracy (0.88-0.9) and AUC (up to 0.93) when using features from the good and excellent reproducibility categories. PCA emerged as the most effective dimensionality reduction method, preserving the discriminative power of reproducible features across all models.

Conclusions:
The results indicate that radiomic feature extraction from MR images, combined with dimensionality reduction and machine learning algorithms, provides a robust approach for prostate cancer diagnosis.
REFERENCES (25)
1.
Chen FZ, Zhao XK. Prostate cancer: current treatment and prevention strategies. Iran Red Cres Med J 2013; 15: 279-284.
 
2.
Rawla P. Epidemiology of prostate cancer. World J Oncol 2019; 10: 63-89.
 
3.
Ohnuma H. 4. Pathology of prostate cancer. Nihon Hoshasen Gijutsu Gakkai Zasshi 2017; 73: 571-577 [Article in Japanese].
 
4.
Tefekli A, Tunc M, Tugcu V, Esen T. Prostate cancer: all aspects. ScientificWorldJournal 2013; 2013: 265234. DOI: 10.1155/2013/265234.
 
5.
Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and prevention of prostate cancer. Eur Urol Oncol 2021; 4: 877-892.
 
6.
Kumar V, Bora GS, Kumar R, Jagannathan NR. Multiparametric (mp) MRI of prostate cancer. Prog Nucl Magn Reson Spectrosc 2018; 105: 23-40.
 
7.
Reda I, Shalaby A, Elmogy M, Aboulfotouh A, Khalifa F, El-Ghar MA, et al. Image-based computer-aided diagnostic system for early dia­gnosis of prostate cancer. In: International Conference on Medical Image Computing and Computer-Assisted Intervention. Springer; 2016, pp. 610-618.
 
8.
Xing X, Zhao X, Wei H, Li Y. Diagnostic accuracy of different computer-aided diagnostic systems for prostate cancer based on magnetic resonance imaging: a systematic review with diagnostic meta-analysis. Medicine (Baltimore) 2021; 100: e23817. DOI: 10.1097/MD.0000000000023817.
 
9.
Litjens GJS, Barentsz JO, Karssemeijer N, Huisman HJ. Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI. Eur Radiol 2015; 25: 3187-3199.
 
10.
Yoo S, Gujrathi I, Haider MA, Khalvati F. Prostate cancer detection using deep convolutional neural networks. Sci Rep 2019; 9: 19518. DOI: 10.1038/s41598-019-55972-4.
 
11.
Bijari S, Sayfollahi S, Mardokh-Rouhani S, Bijari S, Moradian S, Zahiri Z, et al. Radiomics and deep features: robust classification of brain hemorrhages and reproducibility analysis using a 3D autoencoder neural network. Bioengineering 2024; 11: 643. DOI: 10.3390/bioengineering11070643.
 
12.
Mahboubisarighieh A, Shahverdi H, Jafarpoor Nesheli S, Alipoor Kermani M, Niknam M, Torkashvand M, et al. Assessing the efficacy of 3D Dual-CycleGAN model for multi-contrast MRI synthesis. Egypt J Radiol Nucl Med 2024; 55: 1-12.
 
13.
Rezaeijo SM, Harimi A, Salmanpour MR. Fusion-based automated segmentation in head and neck cancer via advance deep learning techniques. In: 3D Head and Neck Tumor Segmentation in PET/CT Challenge. Springer; 2022, pp. 70-76.
 
14.
Whybra P, Zwanenburg A, Andrearczyk V, Schaer R, Apte AP, Ayot­te A, et al. The image biomarker standardization initiative: standardized convolutional filters for reproducible radiomics and enhanced clinical insights. Radiology 2024; 310: e231319. DOI: 10.1148/radiol.231319.
 
15.
Salmanpour MR, Hosseinzadeh M, Akbari A, Borazjani K, Mojallal K, Askari D, et al. Prediction of TNM stage in head and neck cancer using hybrid machine learning systems and radiomics features. In: Medical Imaging 2022: Computer-Aided Diagnosis. SPIE; 2022, pp. 648-653.
 
16.
Mayerhoefer ME, Materka A, Langs G, Häggström I, Szczypiński P, Gibbs P, et al. Introduction to radiomics. J Nucl Med 2020; 61: 488-495.
 
17.
Bijari S, Rezaeijo SM, Sayfollahi S, Rahimnezhad A, Heydarheydari S. Development and validation of a robust MRI-based nomogram incorporating radiomics and deep features for preoperative glioma grading: a multi-center study. Quant Imaging Med Surg 2025; 15: 1121138-1125138.
 
18.
Fatan M, Hosseinzadeh M, Askari D, Sheikhi H, Rezaeijo SM, Salmanpour MR. Fusion-based head and neck tumor segmentation and survival prediction using robust deep learning techniques and advanced hybrid machine learning systems. In: 3D Head and Neck Tumor Segmentation in PET/CT Challenge. Springer; 2021, pp. 211-223.
 
19.
AkbarnezhadSany E, EntezariZarch H, AlipoorKermani M, Shahin B, Cheki M, Karami A, et al. YOLOv8 outperforms traditional CNN models in mammography classification: insights from a multi‐institutional dataset. Int J Imaging Syst Technol 2024; 35: e70008. DOI: 10.1002/ima.70008.
 
20.
Paeenafrakati MS, Hajianfar G, Rezaeijo SM, Ghaemi M, Rahmim A. Advanced automatic segmentation of tumors and survival prediction in head and neck cancer. Lect Notes Comput Sci Challenges; 2022.
 
21.
Rezaeijo SM, Chegeni N, Baghaei Naeini F, Makris D, Bakas S. Within-modality synthesis and novel radiomic evaluation of brain MRI scans. Cancers (Basel) 2023; 15: 3565. DOI: 10.3390/cancers­15143565.
 
22.
Li M, Chen T, Zhao W, Wei C, Li X, Duan S, et al. Radiomics prediction model for the improved diagnosis of clinically significant prostate cancer on biparametric MRI. Quant Imaging Med Surg 2020; 10: 368-379.
 
23.
Zhang Y, Chen W, Yue X, Shen J, Gao C, Pang P, et al. Development of a novel, multi-parametric, MRI-based radiomic nomogram for differentiating between clinically significant and insignificant prostate cancer. Front Oncol 2020; 10: 888. DOI: 10.3389/fonc.2020.00888.
 
24.
Rodrigues A, Rodrigues N, Santinha J, Lisitskaya MV, Uysal A, Matos C, et al. Value of handcrafted and deep radiomic features towards training robust machine learning classifiers for prediction of prostate cancer disease aggressiveness. Sci Rep 2023; 13: 6206. DOI: 10.1038/s41598-023-33339-0.
 
25.
Khanfari H, Mehranfar S, Cheki M, Mohammadi Sadr M, Moniri S, Heydarheydari S, et al. Exploring the efficacy of multi-flavored feature extraction with radiomics and deep features for prostate cancer grading on mpMRI. BMC Med Imaging 2023; 23: 195. DOI: 10.1186/s12880-023-01140-0.
 
Journals System - logo
Scroll to top